Hospital News and Research

RSS

Injuries mount as sales reps for device makers cozy up to surgeons, even in operating rooms

Cristina Martinez's spinal operation in Houston was expected to be routine. But after destabilizing her spine, the surgeon discovered the implant he was ready to put in her back was larger than he wanted to use — and the device company’s sales rep didn’t have a smaller size on hand, according to a report he filed about the operation.

9 Aug 2021

New tabletop device can quickly detect SARS-CoV-2 from saliva samples

Engineers at MIT and Harvard University have designed a small tabletop device that can detect SARS-CoV-2 from a saliva sample in about an hour.

6 Aug 2021

New CRISPR-based diagnostic test detects COVID-19 variants from saliva samples

With the Delta variant wreaking havoc on unvaccinated populations and COVID-19 cases spiking around the world, the pandemic is far from over.

6 Aug 2021

Learn & Lounge helps AYA patients, survivors to connect with peers and get support

Young cancer patients face unique challenges. That's why the UC Davis Comprehensive Cancer Center started an Adolescent and Young Adult (AYA) Oncology Program in 2020.

6 Aug 2021

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health, an institution supported by "la Caixa" Foundation, in collaboration with the Hospital Clinic of Barcelona.

6 Aug 2021

Hard lessons from a city that tried to privatize public health

If you were growing up in Detroit in the 1970s or '80s, chances are you knew the city's Herman Kiefer public health complex by both sight and reputation.

6 Aug 2021

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

A recent study published on the preprint server medRxiv* determines whether the time elapsed since the second dose of the BNT162b2 vaccine is associated with an increased risk of breakthrough SARS-CoV-2 infection.

6 Aug 2021

SARS-CoV-2 Beta variant associated with more critical and fatal disease than Alpha, suggests Qatar study

A new study traces the degree to which the Beta variant of this virus is associated with severe, critical or fatal disease, using a case-control model.

6 Aug 2021

King Edward VII’s new approach reduces damaging side effects of breast cancer surgeries

Independent charitable hospital King Edward VII’s, based in Harley Street Medical Area, is incorporating two new innovations to combat some of the damaging long-term side effects of breast cancer surgeries.

6 Aug 2021

Researchers create new model for studying earliest stages of retinoblastoma

Scientists at St. JudeChildren's Research Hospital have created a laboratory model for studying retinoblastoma driven by inherited mutations in theRB1gene.Retinoblastoma is a rare cancer of the retina, the thin tissue inside the back of the eye.

6 Aug 2021

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill patients has found the treatment improves outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.

6 Aug 2021

Research suggests potential new treatment strategy for phenylketonuria

Researchers at The University of Texas MD Anderson Cancer Center have discovered a critical new factor in regulating phenylalanine metabolism and, therefore, in preventing the inherited metabolic disorder phenylketonuria (PKU).

5 Aug 2021

Researchers develop the most comprehensive molecular map of lung squamous cell carcinoma

Lung cancer remains the leading cause of cancer-associated death in the United States and worldwide. Patients with a subtype called lung adenocarcinoma (LUAD) have benefited from the development of new targeted medicines, but the search for effective new therapies for another subtype called lung squamous cell carcinoma (LSCC) has largely come up short.

5 Aug 2021

Children of heavy drinkers have elevated risk of several adverse experiences

The children of parents who drink alcohol heavily have an elevated risk of a number of adverse experiences, including mental health disorders, hospitalizations and criminal behavior, according to a new review in the Journal of Studies on Alcohol and Drugs.

5 Aug 2021

Specific and sensitive biomarker in the blood predicts symptomatic COVID-19 infection

Researchers remain perplexed as to why some patients infected with SARS-CoV-2, the virus responsible for COVID-19, remain asymptomatic while other patients develop severe disease symptoms.

5 Aug 2021

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Stroke patients were almost twice as likely to be functionally independent - mobile and able to perform daily tasks - at 90 days post-stroke if they were treated by a specialized mobile stroke team that traveled to them to perform mechanical clot removal, compared to those who were transferred to a thrombectomy stroke center, according to research conducted within the Mount Sinai Health System and published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

5 Aug 2021

Poor motor function from around age 65 associated with increased mortality risk

Increasing poor physical (motor) function from around age 65 is associated with an increased risk of death, finds research published by The BMJ today.

5 Aug 2021

RIZE’s XRIZE Full-Color Printer Now Compatible with Synopsys Simpleware for 3D Medical Printing

RIZE, Inc. today announced that its XRIZE® 3D printing platform is compatible with Synopsys’ FDA 510(k)-cleared Simpleware™ software.

From Synopsys Simpleware™ Software 5 Aug 2021

Post-COVID-19 neurological sequalae are not due to brain injury, study shows

In a recent study from University of Gothenburg, it has been shown that all participants achieve normalization of CNS injury biomarkers, regardless of previous disease severity or persistent neurological symptoms. Indicating that post-COVID-19 neurological sequalae are not due to active brain injury.

5 Aug 2021

The role of natural killer cells in the fight against coronavirus infection

This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.

4 Aug 2021

Hospital News and Research

Injuries mount as sales reps for device makers cozy up to surgeons, even in operating rooms

New tabletop device can quickly detect SARS-CoV-2 from saliva samples

New CRISPR-based diagnostic test detects COVID-19 variants from saliva samples

Learn & Lounge helps AYA patients, survivors to connect with peers and get support

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

Hard lessons from a city that tried to privatize public health

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

SARS-CoV-2 Beta variant associated with more critical and fatal disease than Alpha, suggests Qatar study

King Edward VII’s new approach reduces damaging side effects of breast cancer surgeries

Researchers create new model for studying earliest stages of retinoblastoma

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Research suggests potential new treatment strategy for phenylketonuria

Researchers develop the most comprehensive molecular map of lung squamous cell carcinoma

Children of heavy drinkers have elevated risk of several adverse experiences

Specific and sensitive biomarker in the blood predicts symptomatic COVID-19 infection

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Poor motor function from around age 65 associated with increased mortality risk

RIZE’s XRIZE Full-Color Printer Now Compatible with Synopsys Simpleware for 3D Medical Printing

Post-COVID-19 neurological sequalae are not due to brain injury, study shows

The role of natural killer cells in the fight against coronavirus infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News